Cargando…
Response to “Noninvasive prenatal screening at low fetal fraction: comparing whole‐genome sequencing and single‐nucleotide polymorphism methods”
Autores principales: | Muzzey, Dale, Haverty, Carrie, Evans, Eric A., Goldberg, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811916/ https://www.ncbi.nlm.nih.gov/pubmed/28675624 http://dx.doi.org/10.1002/pd.5071 |
Ejemplares similares
-
Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk
por: Muzzey, Dale, et al.
Publicado: (2019) -
Comment on “Noninvasive prenatal screening at low fetal fraction: comparing whole‐genome sequencing and single‐nucleotide polymorphism methods”
por: Ryan, Allison, et al.
Publicado: (2017) -
Inaccuracies and shortcomings in “Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations”
por: Johansen Taber, Katherine, et al.
Publicado: (2019) -
The impact of HBB‐related hemoglobinopathies carrier status on fetal fraction in noninvasive prenatal screening
por: Putra, Manesha, et al.
Publicado: (2022) -
Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management
por: Arjunan, Aishwarya, et al.
Publicado: (2020)